ACQUITY UPLC System Now Supported on Applied Biosystems/MDS SCIEX’s Mass Spectrometers

Waters Corporation announced today that it has released control software that now makes its ACQUITY UltraPerformance LC^® (UPLC) System compatible with Applied Biosystems/MDS SCIEX mass spectrometry products controlled by Analyst^® software.

In conjunction with Applied Biosystems/MDS SCIEX’s release of the latest update to Analyst^® V1.4.2 LC/MS control software, Waters will now supply and support additional software which provides full support for the ACQUITY UPLC Systems, including Waters nanoACQUITY UPLC System, on Applied Biosystems/MDS SCIEX’s mass spectrometry platforms.

In August of last year, Waters and Applied Biosystems/MDS SCIEX entered into an agreement for Waters to develop control software for the ACQUITY UPLC System, with support from Applied Biosystems/MDS SCIEX. The new software from Waters is designed to allow scientists to combine Waters^® UPLC and Applied Biosystems/MDS SCIEX MS technologies and operate them on a single data system. This new level of compatibility is expected to improve laboratory efficiency by giving scientists what they have been asking for: greatly enhanced ease-of-use of the combined technologies.

UPLC technology has proven to produce narrower and sharper peaks versus HPLC, higher signal-to-noise ratios, and shorter run times – all of which contribute to enhanced mass spectrometer performance bringing laboratories new levels of efficiency. By combining liquid chromatography with mass spectrometry, scientists are capable of obtaining much more information from a single analysis than by either technique alone.

Waters retains responsibility for distribution and support of the ACQUITY UPLC System control software. Applied Biosystems/MDS SCIEX retains responsibility for distribution and support of Analyst^® LC/MS control software.